Search - tctmd.com

Displaying 1 - 20 of 616

Sort: Relevancy | Date

News Daily News

Novel VECTOR Procedure Creates Percutaneous Aorto-Coronary Bypass

Yael L. Maxwell

January 14, 2026

Presentation TCT 2025

TCT 1521: Extremely Early Tricuspid Bioprosthetic Valve Degeneration: Diagnostic Evaluation and Successful Transcatheter Valve-in-Valve Intervention

Presenter: Mark Sonbol

October 28, 2025

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Presentation TCT 2025

Challenging Surgical Valves for TAV in SAV: Mitraflow, Trifecta, Stentless Valves and Homografts

Presenter: Keith B. Allen

October 27, 2025

Presentation TCT 2025

Leaflet Modification: When and How?

Presenter: Pedro Arturo Villablanca

October 27, 2025

Presentation TCT 2025

Bioprosthetic Valve Fracture: Benefits and Risks

Presenter: Santiago Garcia

October 27, 2025

Presentation TCT 2025

Procedural Planning for ViV TAVR

Presenter: Chad Alan Kliger

October 27, 2025

Presentation TCT 2025

Long Term Outcomes After TAV in SAVR: Do We Need A Randomized Trial?

Presenter: Michael A. Borger

October 27, 2025

Presentation TCT 2025

TCT 758: Lp(a) and Oxidized Phospholipids as Predictors of Bioprosthetic Valve Dysfunction Following Transcatheter Aortic Valve Implantation

Presenter: Frédéric Beaupré

October 27, 2025

Presentation TCT 2025

TCT 1226: Valve-in-Valve TAVR for Failed Trifecta Surgical Bioprosthetic Aortic Valves

Presenter: Matjaz Bunc

October 26, 2025

Presentation TCT 2025

Featured Clinical Research: Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

Presenter: Philippe Genereux

October 26, 2025

Presentation TCT 2025

TCT 1222: Bioprosthetic Valve Fracture During VIV TAVR with a Self-Expanding Evolut Valve: Safety and Hemodynamics Outcomes from the Transcatheter Valve Therapy Registry

Presenter: Keith B. Allen

October 26, 2025

Presentation TCT 2025

TCT 882: Impact of Different Leaflet and Stent Materials on Bileaflet Bioprosthetic Mitral Valve Performance

Presenter: Joseph Chibuike Nwokeafor

October 26, 2025

Presentation TCT 2025

TCT 1531: Transfemoral Tricuspid Valve-in-Valve (ViV) Procedure in a High-Risk Patient With Bioprosthetic Valve Failure and Prior Infective Endocarditis

Presenter: Khin May Thaw

October 25, 2025

Presentation TCT 2025

TCT 1103: Transcatheter vs. Surgical Replacement of Degenerated Bioprosthetic Aortic Valve Over Time: Findings from a Meta-Analysis of Propensity-Score-Matched Studies

Presenter: Mohammad Javad Namazi

October 25, 2025

Presentation TCT 2025

TCT 229: Association Between Early Bioprosthetic Valve Dysfunction and Long-Term Clinical Outcomes After Transcatheter Aortic Valve Replacement

Presenter: Dhaval Kolte

October 25, 2025

Presentation TCT 2025

TCT 1302: LAVA-ECMO Supported ViV TAVR and PVL Closure in Aortic Bioprosthetic Valve Dehiscence

Presenter: Hon Yeung Ko

October 25, 2025

Presentation TCT 2025

TCT 5: A Novel Nanomaterial Surface Coating for Bioactive Drug Functionalisation of Bioprosthetic Heart Valves

Presenter: Richard Tan

October 25, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Daily News

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

L.A. McKeown

October 09, 2025

Advertisement

Novel VECTOR Procedure Creates Percutaneous Aorto-Coronary Bypass

TCT 1521: Extremely Early Tricuspid Bioprosthetic Valve Degeneration: Diagnostic Evaluation and Successful Transcatheter Valve-in-Valve Intervention

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Challenging Surgical Valves for TAV in SAV: Mitraflow, Trifecta, Stentless Valves and Homografts

Leaflet Modification: When and How?

Bioprosthetic Valve Fracture: Benefits and Risks

Procedural Planning for ViV TAVR

Long Term Outcomes After TAV in SAVR: Do We Need A Randomized Trial?

TCT 758: Lp(a) and Oxidized Phospholipids as Predictors of Bioprosthetic Valve Dysfunction Following Transcatheter Aortic Valve Implantation

TCT 1226: Valve-in-Valve TAVR for Failed Trifecta Surgical Bioprosthetic Aortic Valves

Featured Clinical Research: Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

TCT 1222: Bioprosthetic Valve Fracture During VIV TAVR with a Self-Expanding Evolut Valve: Safety and Hemodynamics Outcomes from the Transcatheter Valve Therapy Registry

TCT 882: Impact of Different Leaflet and Stent Materials on Bileaflet Bioprosthetic Mitral Valve Performance

TCT 1531: Transfemoral Tricuspid Valve-in-Valve (ViV) Procedure in a High-Risk Patient With Bioprosthetic Valve Failure and Prior Infective Endocarditis

TCT 1103: Transcatheter vs. Surgical Replacement of Degenerated Bioprosthetic Aortic Valve Over Time: Findings from a Meta-Analysis of Propensity-Score-Matched Studies

TCT 229: Association Between Early Bioprosthetic Valve Dysfunction and Long-Term Clinical Outcomes After Transcatheter Aortic Valve Replacement

TCT 1302: LAVA-ECMO Supported ViV TAVR and PVL Closure in Aortic Bioprosthetic Valve Dehiscence

TCT 5: A Novel Nanomaterial Surface Coating for Bioactive Drug Functionalisation of Bioprosthetic Heart Valves

What’s Going to Be Hot at TCT 2025

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content